PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion

News   Jun 19, 2017

 
PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion
 
 
 

RELATED ARTICLES

Algorithm Predicts Life Expectancy After Heart Attack

News

A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs.

READ MORE

Stem Cell Signaling Drives Mammary Gland Development

News

New research illuminates the biology of breast tissue development and may pave the way to new strategies for diagnosing or even treating cancer.

READ MORE

Blood Test Rapidly Detects Signs of Pancreatic Cancer

News

The new test can rapidly screen a drop of blood for biomarkers of pancreatic cancer, and provide results in less than an hour.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE